[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"enlarged-prostate-bph\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:enlarged-prostate-bph":86},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,45,64],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100643473",false,"NCT07632742","Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial","MOSES 2.0 vs Quanta Magneto 150 Holmium Laser for Holmium Laser Enucleation of the prostate-a Randomized Controlled Trial","Inclusion Criteria:\n\n* Undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms\n* Internet access and a device to complete postoperative questionnaires (smartphone, tablet, laptop or desktop computer)\n\nExclusion Criteria:\n\n* Patients who lack decisional capacity\n* Patients unable to read\u002Fspeak English\n* Patients who are on a blood thinner (anticoagulation medication)\n* Patients who do not have internet access to complete postoperative surveys",true,"MALE","18 Years","100 Years",{"count":20,"type":21},180,"ESTIMATED","INTERVENTIONAL",[24],"NA","The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.",[27,28],"Enlarged Prostate (BPH)","Benign Prostatic Hyperplasia",[30,31],"HoLEP","Holmium laser","RECRUITING","2026-06-05",{"date":35,"type":36},"2026-06-08","ACTUAL",{"date":38,"type":21},"2026-06",{"date":40,"type":21},"2028-06",{"name":42,"class":43},"Northwestern University","OTHER",1,{"id":46,"slug":4,"hasResults":10,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":51,"targetDuration":4,"studyType":22,"phases":53,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":58,"startDateStruct":60,"completionDateStruct":61,"leadSponsor":63,"locationsCount":44},"100643481","NCT07631286","Ejaculatory-Sparing HoLEP vs Standard HoLEP","Ejaculatory-sparing Holmium Laser Enucleation of the Prostate (HoLEP) vs Standard HoLEP: a Randomized Controlled Trial","Inclusion Criteria:\n\n\\- Patients who are sexually active with antegrade ejaculation who are undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms.\n\nExclusion Criteria:\n\n* Patients with pre-existing retrograde ejaculation\n* Patients who are not sexually active\n* Patients with indwelling urinary catheter prior to surgery, neurological disease, or history of prior prostatic\u002Furethral surgery that may impact ejaculation\n* Patients who lack decisional capacity\n* Patients unable to read\u002Fspeak English",{"count":52,"type":21},48,[24],"The objective of this study is to compare a new surgical technique for HoLEP that will allow for sparing of ejaculation post-HoLEP.",[27,56],"Enlarged Prostate With Lower Urinary Tract Symptoms",[30],{"date":59,"type":36},"2026-06-09",{"date":38,"type":21},{"date":62,"type":21},"2028-05",{"name":42,"class":43},{"id":65,"slug":4,"hasResults":10,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":4,"eligibilityCriteria":69,"healthyVolunteers":15,"sex":16,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":4,"studyType":22,"phases":74,"briefSummary":75,"conditions":76,"keywords":77,"overallStatus":79,"whyStopped":4,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":83,"completionDateStruct":84,"leadSponsor":85,"locationsCount":44},"100637217","NCT07580404","Emsella for Reducing tSUI After HOLEP","The Utility of Emsella for Reducing Transient Stress Urinary Incontinence (tSUI) Following Holmium Laser Enucleation of the Prostate (HoLEP)","Inclusion Criteria:\n\n* Prostate sizing 80-150g\n* Ability to independently transfer and tolerate all 30min Emsella treatments (e.g. not wheelchair bound, no mobility issues)\n* Baseline M-ISI scores \\\u003C4\n* Same-day catheter removal and discharge\n* Able to read, understand, and complete surveys and questionnaires\n\nExclusion Criteria:\n\n* Catheter dependence\n* Previous BPH procedure\n* Previous pelvic surgeries\n* Pre-existing pelvic floor dysfunction\n* Neurogenic bladder\n* Overactive bladder - e.g. prescribed and taking any oxybutynin or mirabegron\n* Preoperative pad-use for incontinence","50 Years","80 Years",{"count":73,"type":21},30,[24],"This study aims to investigate the effectiveness of the Emsella chair treatments at different timepoints. Before and after the holmium laser enucleation of the prostate (HoLEP).",[28,56,27],[30,78],"Emsella","NOT_YET_RECRUITING","2026-05-05",{"date":82,"type":36},"2026-05-12",{"date":38,"type":21},{"date":40,"type":21},{"name":42,"class":43},""]